Prometheus Therapeutics Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-11-12.
Prometheus Therapeutics Inc. filed an amended Form D notice of an exempt securities offering with the SEC on November 12, 2025. The filing reports $2.75M sold. Its industry group is Other Health Care. It names Ajay Wakhloo (Executive Officer, Director), Alexander Hastings (Director), Baruch Lieber (Executive Officer, Director) (SEC Form D/A, November 12, 2025).
Is this your company?
Sell to companies like Prometheus Therapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-11-12 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Prometheus Therapeutics Inc.
Free to see. No signup.
More on the people and the money behind Prometheus Therapeutics Inc., from the filings we hold.
Other Health Care raises by companies based in Florida, filed within 90 days of this one, largest first.
Get an email when Prometheus Therapeutics Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Prometheus Therapeutics Inc. raises, hires or launches. No email unless you switch it on.
Watch Prometheus Therapeutics Inc. →Get the full cited report on Prometheus Therapeutics Inc.
What the filing shows about Prometheus Therapeutics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Prometheus Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Prometheus Therapeutics Inc.'s address as 10370 USA Today Way, Miramar, FL 33025.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Prometheus Therapeutics Inc. →
Amended on 2026-04-15: the offering size changed from $5,000,000 to $6,500,000; the amount sold changed from $130,000 to $2,745,000; the number of investors changed from 3 to 13. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Prometheus Therapeutics Inc. See pricing
Prometheus Therapeutics Inc. is a registered filer with the SEC (CIK 1823161) and has filed since 2023-02-13. 2 filings are on record, the latest on 2025-11-12.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Prometheus Therapeutics Inc.'s Form D of 2025-11-12 names Ajay Wakhloo, Alexander Hastings, Baruch Lieber and 2 more as its officers, directors or promoters.
Its new offerings report $1.18M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 871 filings in Other Health Care, totalled by week. The dot is this raise, $2.75M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Ajay Wakhloo is named as Executive Officer and Director on the Form D that Prometheus Therapeutics Inc. filed with the SEC on 12 November 2025, one of 5 people that filing names.
Alexander Hastings is named as Director on the Form D that Prometheus Therapeutics Inc. filed with the SEC on 12 November 2025, one of 5 people that filing names.
Baruch Lieber is named as Executive Officer and Director on the Form D that Prometheus Therapeutics Inc. filed with the SEC on 12 November 2025, one of 5 people that filing names.
John McEleney is named as Director on the Form D that Prometheus Therapeutics Inc. filed with the SEC on 12 November 2025, one of 5 people that filing names.
Bernie Navarro is named as Executive Officer on the Form D that Prometheus Therapeutics Inc. filed with the SEC on 12 November 2025, one of 5 people that filing names.
5 people named on the filing — 3 holding an executive role and 2 as directors only.
Named as of the 2025-11-12 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Prometheus Therapeutics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Prometheus Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Prometheus Therapeutics Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Prometheus Therapeutics Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Prometheus Therapeutics Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Prometheus Therapeutics Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/prometheus-therapeutics-inc-form-d-25000001